“…The Robotic versus Laparoscopic Resection for Rectal Cancer (ROLARR) study, for example, the largest international randomized control trial yet undertaken to compare the safety, efficacy, and short-and long-term outcomes of a robotic colorectal procedure compared with conventional laparoscopy, found no statistically significant difference in conversion rates to open laparotomy, circumferential resection margins, mesorectal resection quality, postoperative complications within 30 days, and quality of life on month 6 after operation. 1,6 There is a body of evidence from cohort and case-controlled studies into the use of robotics in rectal cancer resection (including TME) that suggests benefits in terms of all-cause mortality, surgical site infection, intraoperative blood loss, time to oral diet, postoperative ileus and preservation of sphincter, and urinary and sexual function, especially in obese men. 1,6 However, in 2019, Liao et al published a meta-analysis of seven randomized controlled trials (RCTs) comparing robotic and laparoscopic surgery of the rectum and again found no statistically significant differences in similar outcomes covered by ROLARR, including circumferential and proximal resection margins (it actually found that distal resection margins were longer in robot-assisted procedures, although significant heterogeneity in the data was noted across studies).…”